Koji Mitsuzuka

About

Koji Mitsuzuka is a leading urologic oncologist whose research focuses on optimizing outcomes for prostate cancer patients, particularly through surgical precision and cost-effective treatment strategies. His work has significantly advanced the understanding of postoperative urinary incontinence, a critical quality-of-life concern. In a highly cited 2022 study (11 citations), Mitsuzuka demonstrated that minimal residual membranous urethral length (mRUL) on preoperative MRI is a powerful predictor of poor urinary recovery after both robot-assisted and open radical prostatectomy, providing surgeons with a vital tool for patient counseling and surgical planning. He also made notable contributions to health economics, using data from the PRIAS-JAPAN study (8 citations) to compare medical costs of active surveillance versus aggressive treatments for low-risk prostate cancer in Japan, offering crucial evidence for value-based care. Additionally, his work on evaluating elderly men for radical prostatectomy (6 citations) addresses the nuanced controversies in geriatric oncology. Through these impactful studies, Mitsuzuka bridges surgical technique, patient quality of life, and healthcare economics, establishing himself as a key voice in modern prostate cancer management.

Research Focus

Key Achievements

Top Papers

1. 1
   Minimal residual membranous urethral length and membranous urethral length predict poor recovery from incontinence after robot‐assisted radical prostatectomy and after open radical prostatectomy

   11 citations · 2022
2. 2
   Comparison of the medical costs between active surveillance and other treatments for early prostate cancer in Japan using data from the PRIAS‐JAPAN study

   8 citations · 2022
3. 3
   Controversies associated with the evaluation of elderly men with localized prostate cancer when considering radical prostatectomy

   6 citations · 2014

Key Collaborators

Contact & Links